Thomas Hadley is a seasoned pharmaceutical executive, currently President and CEO of Thoclor US, Inc. He recently led UTILITY therapeutics to a major success, securing the first FDA approval for a new UTI antibiotic in 20 years and overseeing the companys acquisition. Colleagues describe him as strategic, creative, and hands-on.
Beyond his corporate leadership, Thomas is dedicated to community impact, serving as a Board Member for Teach For America in New Jersey. This role reflects his commitment to supporting educational initiatives and contributing to local community development.
He led the development and FDA approval of PIVYA, the first new antibiotic for uncomplicated urinary tract infections in over two decades.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.